trial

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

NCTId NCT01548612
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 20 (actual)
Sponsored by University of Sao Paulo
Primary completion 2009-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
20 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2006-02
Primary completion
2009-06
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Sodium nitroprussideGlucose solution

Sponsors

University of Sao PauloLead Sponsor

Investigators

1
Jaime EC Hallak, DoctorPrincipal Investigator

Sites

1 total
Ribeirão Preto, Brazil

Linked catalysts

1
Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia — primary completion2009-06

Facts & assertions

4 sourced
Enrollment
20
Phase
PHASE2
Primary Completion Date
2009-06
Status
COMPLETED
relationships
The graph out of here
drug
Sodium nitroprusside
drug
Glucose solution
drug
lead_sponsor
University of Sao Paulo
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Jaime EC Hallak, Doctor
person